Press Resease

Pharmaceutical Intermediates Market To Procure Huge Returns Worth USD 39,779 Million By 2028

Pharmaceutical Intermediates Market - Global Industry Analysis

Pharmaceutical Intermediates Market - By Application (Antibiotics, Antipyretic Analgesics, and Vitamins), By Product Type (GMP and Non-GMP), By Distribution Channel (Direct Sales and Distributor), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2028

Published Date: 23-Nov-2021 Category: Pharmaceutical Report Format : PDF Pages: 187 Report Code: ZMR-3440 Status : Published

The global Pharmaceutical Intermediates Market accrued earnings worth approximately 28,117 (USD Million) in 2020 and is predicted to gain revenue of about 39,779 (USD Million) by 2028, is set to record a CAGR of nearly 4.1% over the period from 2021 to 2028.

Request For Customization Request Free Brochure Request Free Sample Buy Now

Description

The global Pharmaceutical Intermediates Marketaccrued earnings worth approximately 28,117 (USD Million) in 2020and is predicted to gain revenue of about 39,779 (USD Million) by2028, is set to record a CAGR of nearly 4.1% over the period from2021 to 2028. The report offers assessment and analysis of thePharmaceutical Intermediates Market on a globaland regional level. The study offers a comprehensive assessment ofthe market competition, constraints, revenue estimates,opportunities, evolving trends, and industry-validated data. Thereport provides historical data from 2018 to 2020 along with aforecast from 2021 to 2028 based on revenue (USD Million).

Pharmaceutical Intermediates Market:Overview

Pharmaceutical Intermediates are utilized as raw componentsduring bulk drug production. Moreover, they are chemical compoundsthat form building blocks of active pharmaceutical ingredient(API). These products are produced as by-products while producingAPI. Nonetheless, bio-pharma and pharma firms are focusing onimproving their product reach in various countries across globe.These firms are trying to increase production capacities indifferent parts of globe.

Pharmaceutical Intermediates Market: GrowthDrivers

Report Scope:

Report Attribute	Details
Base Year	2020
Historic Years	2016 - 2020
Forecast Years	2021 - 2028
Segments Covered	By Product Type, By Application, and By End Use
Forecast Units	Value (USD Billion), and Volume (Units)
Quantitative Units	Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered	North America, Europe, Asia Pacific, Latin America, and MiddleEast & Africa, and Rest of World
Countries Covered	U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain,China, India, Japan, South Korea, Brazil, Argentina, GCC Countries,and South Africa, among others
Number of Companies Covered	10 companies with scope for including additional 15 companiesupon request
Report Coverage	Market growth drivers, restraints, opportunities, Porter?s fiveforces analysis, PEST analysis, value chain analysis, regulatorylandscape, market attractiveness analysis by segments and region,company market share analysis, and COVID-19 impact analysis.
Customization Scope	Avail customized purchase options to meet your exact researchneeds.

Furthermore, wide use of Pharmaceutical Intermediates Market indomain of clinical research will prompt business expansion inupcoming years. In addition to this, outbreak of COVID-19 pandemichas encouraged players in biotech and pharmaceutical sectors tofocus on drug production activities, thereby enlarging scope ofPharmaceutical Intermediates industry over assessment period.

Regional Landscape

North America To Dominate Overall Market Growth By2028

Expansion of Pharmaceutical Intermediates Market in NorthAmerica over assessment period is due to surge in research &development activities in countries such as Canada and the U.S.Apart from this, surge in occurrence of myriad chronic conditionswill further contribute towards regional market proceeds overupcoming years. For the record, heart disorder causes nearly 8 lacdeaths in the U.S.

Competitive Landscape

Key participants leveraging growth of PharmaceuticalIntermediates Market and profiled in study include Codexis, Inc.,Midas Pharma GmbH, Cycle Pharma, Dextra Laboratories Ltd., BASF SE,Chemcon Specialty Chemicals Pvt. Ltd, A.R. Life Sciences PrivateLimited, Dishman Group, Sanofi Winthrop Industrie S.A., ZCLChemicals Ltd., Vertellus Holdings LLC, Aceto Corporation,Lianhetech, and Easter Chemical Corporation.

The global Pharmaceutical Intermediates Market is segmented asfollows:

By Application

Antibiotics
Vitamins
Antipyretic Analgesics

By Distribution Channel

Direct Sales
Distributor

By Product Type

GMP
Non-GMP

By Region

North America
- The U.S.
- Canada
Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa

Table Of Content

Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodulogy
  - 1.3.1. Market Research Type
  - 1.3.2. Market Research Methodulogy
Chapter 2. Executive Summary
- 2.1. Pharmaceutical Intermediates Market, 2018–2028(USD Million)
- 2.2. Pharmaceutical Intermediates Market: Snapshot
Chapter 3. Global Pharmaceutical Intermediates Market– Industry Analysis
- 3.1. Pharmaceutical Intermediates Market: Market Dynamics
- 3.2. Market Drivers
  - 3.2.1. Surge in incidence of chronic ailments such as diabetes, heart disorders, and kidney problems will bulster industry trends.
  - 3.2.2. Expanding reach of myriad pharma players in emerging countries will enhance scope of Pharmaceutical Intermediates Market growth over assessment timespan.
- 3.3. Porter’s Five Forces Analysis
- 3.4. Market Attractiveness Analysis
  - 3.4.1. Market attractiveness analysis By Application
  - 3.4.2. Market attractiveness analysis By Product Type
  - 3.4.3. Market attractiveness analysis By Distribution Channel
Chapter 4. Global Pharmaceutical Intermediates Market– Competitive Landscape
- 4.1. Company market share analysis
  - 4.1.1. Global Pharmaceutical Intermediates Market: company market share, 2019
- 4.2. Strategic development
  - 4.2.1. Acquisitions & mergers
  - 4.2.2. New Product launches
  - 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
  - 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
Chapter 5. Global Pharmaceutical Intermediates Market– Application Analysis
- 5.1. Global Pharmaceutical Intermediates Market overview: By Application
  - 5.1.1. Global Pharmaceutical Intermediates Market share, By Application, 2020 and 2028
- 5.2. Antibiotics
  - 5.2.1. Global Pharmaceutical Intermediates Market by Antibiotics, 2018–2028(USD Million)
- 5.3. Vitamins
  - 5.3.1. Global Pharmaceutical Intermediates Market by Vitamins, 2018–2028(USD Million)
- 5.4. Antipyretic Analgesics
  - 5.4.1. Global Pharmaceutical Intermediates Market by Antipyretic Analgesics, 2018–2028(USD Million)
Chapter 6. Global Pharmaceutical Intermediates Market– Product Type Analysis
- 6.1. Global Pharmaceutical Intermediates Market overview: By Product Type
  - 6.1.1. Global Pharmaceutical Intermediates Market share, By Product Type, 2020 and 2028
- 6.2. GMP
  - 6.2.1. Global Pharmaceutical Intermediates Market by GMP , 2018–2028(USD Million)
- 6.3. Non-GMP
  - 6.3.1. Global Pharmaceutical Intermediates Market by Non-GMP, 2018–2028(USD Million)
Chapter 7. Global Pharmaceutical Intermediates Market overview: By Distribution Channel
- 7.1. Global Pharmaceutical Intermediates Marketshare, By Distribution Channel , 2020 and 2028
- 7.2. Direct Sales
  - 7.2.1. Global Pharmaceutical Intermediates Marketby Direct Sales, 2018–2028(USD Million)
- 7.3. Distributor
  - 7.3.1. Global Pharmaceutical Intermediates Marketby Distributor, 2018–2028(USD Million)
Chapter 8. Company Profiles
- 8.1. Codexis, Inc.
  - 8.1.1. Overview
  - 8.1.2. Financials
  - 8.1.3. Product Portfulio
  - 8.1.4. Business Strategy
  - 8.1.5. Recent Developments
- 8.2. Midas Pharma GmbH
  - 8.2.1. Overview
  - 8.2.2. Financials
  - 8.2.3. Product Portfulio
  - 8.2.4. Business Strategy
  - 8.2.5. Recent Developments
- 8.3. Cycle Pharma
  - 8.3.1. Overview
  - 8.3.2. Financials
  - 8.3.3. Product Portfulio
  - 8.3.4. Business Strategy
  - 8.3.5. Recent Development
- 8.4. Dextra Laboratories Ltd.
  - 8.4.1. Overview
  - 8.4.2. Financials
  - 8.4.3. Product Portfulio
  - 8.4.4. Business Strategy
  - 8.4.5. Recent Development
- 8.5. BASF SE
  - 8.5.1. Overview
  - 8.5.2. Financials
  - 8.5.3. Product Portfulio
  - 8.5.4. Business Strategy
  - 8.5.5. Recent Development
- 8.6. Chemcon Specialty Chemicals Pvt. Ltd
  - 8.6.1. Overview
  - 8.6.2. Financials
  - 8.6.3. Product Portfulio
  - 8.6.4. Business Strategy
  - 8.6.5. Recent Development
    - 8.7. A.R. Life Sciences Private Limited
  - 8.7.1. Overview
  - 8.7.2. Financials
  - 8.7.3. Product Portfulio
  - 8.7.4. Business Strategy
  - 8.7.5. Recent Development
- 8.8. Dishman Group
  - 8.8.1. Overview
  - 8.8.2. Financials
  - 8.8.3. Product Portfulio
  - 8.8.4. Business Strategy
  - 8.8.5. Recent Development
- 8.9. Sanofi Winthrop Industrie S.A.
  - 8.9.1. Overview
  - 8.9.2. Financials
  - 8.9.3. Product Portfulio
  - 8.9.4. Business Strategy
  - 8.9.5. Recent Development
- 8.10. ZCL Chemicals Ltd.
  - 8.10.1. Overview
  - 8.10.2. Financials
  - 8.10.3. Product Portfulio
  - 8.10.4. Business Strategy
  - 8.10.5. Recent Development
- 8.11. Easter Chemical Corporation
  - 8.11.1. Overview
  - 8.11.2. Financials
  - 8.11.3. Product Portfulio
  - 8.11.4. Business Strategy
  - 8.11.5. Recent Development
- 8.12. Lianhetech
  - 8.12.1. Overview
  - 8.12.2. Financials
  - 8.12.3. Product Portfulio
  - 8.12.4. Business Strategy
  - 8.12.5. Recent Development
- 8.13. Aceto Corporation
  - 8.13.1. Overview
  - 8.13.2. Financials
  - 8.13.3. Product Portfulio
  - 8.13.4. Business Strategy
  - 8.13.5. Recent Development
- 8.14. Vertellus Huldings LLC
  - 8.14.1. Overview
  - 8.14.2. Financials
  - 8.14.3. Product Portfulio
  - 8.14.4. Business Strategy
  - 8.14.5. Recent Development

List of Figures

1. Market research Type
2. Market research methodology
3. Global Pharmaceutical Intermediates Market, 2018–2028(USD Million)
4. Porter’s Five Forces Analysis
5. Global Pharmaceutical Intermediates Marketattractiveness, By Application
6. Global Pharmaceutical Intermediates Marketattractiveness, By Product Type
7. Global Pharmaceutical Intermediates Marketattractiveness, By Distribution Channel
8. Global Pharmaceutical Intermediates Marketshare by Application ,2020 and 2028 (USD Million)
9. Global Pharmaceutical Intermediates Marketby Antibiotics, 2018–2028(USD Million)
10. Global Pharmaceutical Intermediates Marketby Vitamins, 2018–2028(USD Million)
11. Global Pharmaceutical Intermediates Marketby Antipyretic Analgesics, 2018–2028(USD Million)
12. Global Pharmaceutical Intermediates Marketshare by Product Type,2020 and 2028 (USD Million)
13. Global Pharmaceutical Intermediates Marketby GMP, 2018–2028(USD Million)
14. Global Pharmaceutical Intermediates Marketby Non-GMP, , 2018–2028(USD Million)
15. Global Pharmaceutical Intermediates Marketshare by Distribution Channel ,2020 and 2028 (USD Million)
16. Global Pharmaceutical Intermediates Marketby Direct Sales, 2018–2028(USD Million)
17. Global Pharmaceutical Intermediates Marketby Distributor, 2018–2028(USD Million)
18. Global Pharmaceutical Intermediates Marketshare, by Region, 2020 and 2028
19. North America Pharmaceutical Intermediates Market, 2018–2028(USD Million)
20. Europe Pharmaceutical Intermediates Market, 2018–2028(USD Million)
21. Asia Pacific Pharmaceutical Intermediates Market, 2018–2028(USD Million)
22. Latin America Pharmaceutical Intermediates Market, 2018–2028(USD Million)
23. The Middle East and Africa Pharmaceutical Intermediates Market, 2018–2028(USD Million)

List of Tables

1. Global Pharmaceutical Intermediates Market: snapshot
2. Drivers of the Pharmaceutical Intermediates Market: impact analysis
3. North America Pharmaceutical Intermediates Market revenue, By Application ,2018–2028(USD Million)
4. North America Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
5. North America Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
6. The U.S. Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
7. The U.S. Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
8. The U.S. Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
9. Rest of North America Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
10. Rest of North America Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
11. Rest of North America Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
12. Europe Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
13. Europe Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
14. Europe Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
15. UK Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
16. UK Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
17. UK Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
18. France Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
19. France Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
20. France Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
21. Germany Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
22. Germany Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
23. Germany Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
24. Rest of Europe Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
25. Rest of Europe Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
26. Rest of Europe Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
27. Asia Pacific Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
28. Asia Pacific Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
29. Asia Pacific Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
30. China Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
31. China Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
32. China Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
33. Japan Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
34. Japan Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
35. Japan Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
36. India Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
37. India Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
38. India Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
39. Rest of Asia Pacific Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
40. Rest of Asia Pacific Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
41. Rest of Asia Pacific Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
42. Latin America Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
43. Latin America Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
44. Latin America Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
45. Brazil Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
46. Brazil Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
47. Brazil Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
48. Rest of Latin America Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
49. Rest of Latin America Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
50. Rest of Latin America Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
51. The Middle East and Africa Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
52. The Middle East and Africa Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
53. The Middle East and Africa Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
54. Saudi Arabia Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
55. Saudi Arabia Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
56. Saudi Arabia Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
57. South Africa Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
58. South Africa Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
59. South Africa Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)
60. Rest of the Middle East & Africa Pharmaceutical Intermediates Market Revenue, By Application ,2018–2028(USD Million)
61. Rest of the Middle East & Africa Pharmaceutical Intermediates Market Revenue, By Product Type ,2018–2028(USD Million)
62. Rest of the Middle East & Africa Pharmaceutical Intermediates Market Revenue, By Distribution Channel ,2018–2028(USD Million)

Methodology

Free Analysis

Pharmaceutical intermediates are chemical compounds which form the building blocks of the active pharmaceutical ingredient (API). Pharmaceutical intermediates are produced as a by-product during the production of API. Every reaction in the production process of API gives rise to various different pharmaceutical intermediates. Pharmaceutical intermediates are used in the production of bulk drugs and also for research and development purpose by various pharma and biopharma companies. The rapidly growing pharmaceutical industry coupled with research and development activities will lead to various product launches in the industry over the period.

One of the major factors driving the growth of pharmaceutical intermediates market over the forecast period is the thriving pharmaceutical industry. Increasing burden of various diseases such as infectious diseases, chronic diseases, and other diseases is projected to result in the rise in the demand for pharmaceuticals, which, in turn, will support the growth of pharmaceutical intermediates market. As per the Centers for Disease Control and Prevention 2017 report, there were around 16.8 million visits to a physician for infectious and parasitic diseases. Moreover, the constant increase in research and development activities by major market players for the development and innovation of various new drugs are also expected to drive the growth of pharmaceutical intermediates market. Large numbers of patents are moving towards expiry which will increase the market for generics and support the growth of pharmaceutical intermediates market. However, the stringent regulatory scenario is expected to inhibit the growth of pharmaceutical intermediates market over the forecast period.

Global Pharmaceutical Intermediates Market

Pharmaceutical intermediates are classified on the basis of product type, application, and distribution channel. On the basis of product type, pharmaceutical intermediates market is segmented into GMP and non GMP. On the basis of application, pharmaceutical intermediates market is segmented into antibiotics, antipyretic analgesics, vitamins, and others. On the basis of the distribution channel, pharmaceutical intermediates are segmented into direct sales and distributor.

Pharmaceutical intermediates market is regionally segmented into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. North America is expected to dominate the pharmaceutical intermediates market over the forecast period. Europe is expected to closely follow North America in terms of revenue. The Asia Pacific is the fastest growing region over the forecast period, owing to the presence of developing economies. The Middle East and Africa market are expected to expand at a considerable rate over the forecast period.

Some of the major market players of pharmaceutical intermediates market are Aceto Corporation, ZCL Chemical Ltd., A.R. Life Sciences Private Limited, Vertellus Holdings LLC, Lianhetech, Dishman Group, Midas Pharma GmbH, Codexis, Chemcon Specialty Chemical Pvt. Ltd., Cycle Pharma Chem, Easter Chemical Corporation, Dextra Laboratories Limited, BASF SE, and Sanofi Winthrop Industries, among others.

Choose License Type

Single User License

$4199.00 Multi User License

$5199.00 Enterprise Access License

$7199.00

Request the coronavirus impact analysis across industries and markets

Request impact analysis
on this market

FrequentlyAsked Questions

Which key factors will influence the Pharmaceutical Intermediates Market growth over 2021-2028?

Rise in occurrence of chronic disorders such as diabetes, heart ailments, and kidney-related problems will drive market trends. As per WHO, persons above sixty years of age is projected to surpass 2 billion by 2050. Reportedly, WHO has also claimed diabetes to be major cause of heart attack, kidney failure, and stoke. In addition to this, prominently surging geriatric population will embellish growth of Pharmaceutical Intermediates Market over anticipated timeline. Apparently, use of new technologies including high throughput, combinatorial chemistry, and bio-informatics will prop up expansion of Pharmaceutical Intermediates industry over forecast timespan. Growing reach of various pharma players in emerging economies will pave way for expansion of Pharmaceutical Intermediates Market over assessment timeline. Furthermore, wide use of Pharmaceutical Intermediates Market in domain of clinical research will prompt business expansion in upcoming years. In addition to this, outbreak of COVID-19 pandemic has encouraged players in biotech and pharmaceutical sectors to focus on drug production activities, thereby enlarging scope of Pharmaceutical Intermediates industry over assessment period.

What will be the value of the Pharmaceutical Intermediates Market during 2021-2028?

According to Zion market research report, the global Pharmaceutical Intermediates Market accrued earnings worth approximately 28,117 (USD Million) in 2020 and is predicted to gain revenue of about 39,779 (USD Million) by 2028, is set to record a CAGR of nearly 4.1% over the period from 2021 to 2028.

Which region will contribute notably towards the global Pharmaceutical Intermediates Market revenue?

North America will contribute lucratively towards the global market earnings over the projected timeline. The regional market surge is subject to surge in research & development activities in countries such as Canada and the U.S. Apart from this, surge in occurrence of myriad chronic conditions will further contribute towards regional market proceeds over upcoming years. For the record, heart disorder causes nearly 8 lac deaths in the U.S.

Which are the major players impacting Pharmaceutical Intermediates Market growth?

The key market participants include Codexis, Inc., Midas Pharma GmbH, Cycle Pharma, Dextra Laboratories Ltd., BASF SE, Chemcon Specialty Chemicals Pvt. Ltd, A.R. Life Sciences Private Limited, Dishman Group, Sanofi Winthrop Industrie S.A., ZCL Chemicals Ltd., Vertellus Holdings LLC, Aceto Corporation, Lianhetech, and Easter Chemical Corporation.